Feb 24 2010
MeadWestvaco Corp. announced today results from an online survey of 100
pharmacists in the UK regarding their preference for
dispensing preservative-free nasal medications. The survey showed that
67 percent of UK pharmacists have a preference for dispensing a
preservative-free drug. This percentage increased significantly to 84
percent after the benefits of preservative-free drugs were reviewed with
these pharmacists.
“The UK pharmacist survey results demonstrate that, given the option,
preservative-free applications are overwhelmingly preferred by
pharmacists”
MWV developed the preservative-free
nasal pump (PFP N) to address demand for delivery systems that
protect preservative-free drugs from contamination. Patients taking
preservative-free (PF) medications have a reduced incidence of nasal
irritation and sensitivity compared to patients taking medications that
contain preservatives. PFP N permits patients to benefit
from preservative-free medications and their favourable side effect
profiles.
The survey results were consistent with the responses of US physicians
surveyed and demonstrated that UK pharmacists prefer
preservative-free applications because they are trusted to cause fewer
side effects and negative reactions. Pharmacists reported a lower
incidence of nasal irritation and rebound as reasons for preferring
preservative-free medications.
“The UK pharmacist survey results demonstrate that, given the option,
preservative-free applications are overwhelmingly preferred by
pharmacists,” said Julia Amadio, vice president Global Marketing, MWV
Healthcare. “These results show the pharmacists’ concern for
consumer preferences for gentler products that cause less uncomfortable
side effects. As such, the PFP Nasal primary component is the preferred
choice for nasal sprays for both health care providers and patients.”
PFP N provides key benefits to patients, drug manufacturers and brand
owners:
-
Patients can count on a safe and reliable pump that delivers
consumer-preferred and preservative-free products and formulations.
-
Patients enjoy a gentler nasal experience with less irritation and
stinging that can be caused by preservatives.
-
PFP N ensures protection from contamination while providing confidence
in preservative-free formulation protection.
-
Patients can use preservative-free drugs in PFP N without worrying
about the potential side effects caused by some preservatives and the
related short- and long-term consequences, such as rhinitis
medicamentosa (“rebound nasal congestion”).
MWV’s proprietary
technology enables the pump to deliver completely preservative-free
formulations while providing shelf life similar to traditional
formulations. The PFP N is a safe pump for any liquid formula, and its
sealing technology – a mechanical system that protects formulas by
sealing in five places – ensures the drug is kept 100 percent germ-free
after multiple uses. Unlike other pumps, MWV’s PFP N does not use a
silver or metal coil for sterilisation. Silver and metal coils can have
a negative interaction with the drug formula itself.
The PFP N are designed to deliver volumes ranging from 0.05 ml to 0.14
ml. MWV works with customers to ensure products are customised to meet
specific needs, supported throughout the supply chain and that all
regulatory and pharmaceutical standards are met.